JLE

Sang Thrombose Vaisseaux

MENU

Deep vein thrombosis in patients with Covid-19 pneumonia Volume 32, issue 6, Novembre-Décembre 2020

Tables

Authors
1 Hôpital Lariboisière, réanimation médicale et toxicologique, 2, rue Ambroise Paré, 75010 Paris, France
2 INSERM UMRS-1144, Université de Paris, Paris, France
3 Hôpital Lariboisière, service de physiologie et explorations fonctionnelles, 2, rue Ambroise Paré, 75010 Paris, France
4 INSERM U1148, Université de Paris, Paris, France
* Tirés à part

Patients with Covid-19 pneumonia are predisposed to thromboembolic complications due to a hypercoagulable state and endotheliopathy. This mini-review analyzes the main studies regarding deep vein thrombosis and its prevalence which ranges in intensive care patients from 46 % to 86 % according to the studied patients, the type of thromboprophylaxis administered and the number of doppler ultrasound examinations performed during the hospital stay to establish the diagnosis of thrombosis. The implications for clinical practice, and therapeutic perspectives are discussed. Randomized studies comparing several anticoagulation strategies are underway and will enable in the close future therapeutic choices optimizing the risk/benefit ratio.